Your Article Summary
See Latest ArticlesToward effective immunotherapy for the treatment of malignant brain tumors
Neurotherapeutics, 07/01/09
Mitchell DA et al. - In a review of effective immunotherapy for treatment of malignant brain tumors (MBTs), this article will focus on some of the most important breakthroughs in understanding of how to generate potent anti-tumor immune responses, and some of the challenges that lie ahead in achieving effective immunotherapy for the majority of pts with MBTs.
Methods- Immunologic treatment of cancer has long been heralded as a targeted molecular therapeutic with the promise of eradicating tumor cells with minimal damage to surrounding normal tissues.
- A demonstrative example of the efficacy of immunotherapy in modulating cancer progression is still lacking for most human cancers.
- Recent breakthroughs in understanding of the mechanisms leading to full T-cell activation, and recognition of the importance of overcoming tumor-induced immunosuppressive mechanisms, have shed new light on how to generate effective anti-tumor immune responses in humans, and sparked a renewed and enthusiastic effort to realize the full potential of cancer immunotherapy.
- Immunologic treatment of invasive MBTs has not escaped this re-invigorated endeavor, and promising therapies are currently under active investigation in dozens of clinical trials at several institutions worldwide.
- A review of immunotherapeutic strategies currently under clinical evaluation, as well as an outline of promising novel approaches on the horizon, is included to provide perspective on the active and stalwart progress toward effective immunotherapy for the treatment of MBTs.
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Kinase Inhibitors Sunitinib and Sorafenib Differentially Affect NK Cell Antitumor Reactivity In Vitro
Journal of Immunology, 12/16/09
Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients
Cancer Immunology, Immunotherapy, 12/14/09
Today in Neurologic/Ophthalmic...keeping you current
Receive free subspecialty "5-minute updates" via email
Methylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis
Journal of Neuroinflammation, 12/16/09
Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease
Journal of Neuroinflammation, 12/14/09
Beta-Defensins 2 and 3 Together Promote Resistance to Pseudomonas aeruginosa Keratitis
Journal of Immunology, 12/10/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Reactogenicity and Immunogenicity of Combined Haemophilus influenzae Type b-Meningococcal Serogroup C Conjugate Vaccine Booster Dose Coadministered With Measles, Mumps, and Rubella VaccineHib-MenC-TT Booster With Routine MMR Vaccine
The Pediatric Infectious Disease Journal, 12/16/09
Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit
Scandinavian Journal of Immunology, 12/16/09
Novel Approach to the Formulation of an Epstein-Barr Virus Antigen-Based Nasopharyngeal Carcinoma Vaccine
Journal of Virology, 12/16/09